APOE and Alzheimer disease: Hence, iNs of AD patients (hereafter denoted as “AD patient-derived iNs”) with a human APOE ε4 background would provide a useful approach to understanding the pathogenesis of APOE ε4-mediated sporadic AD and facilitating further therapeutic discovery.